Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade
- 1 October 2000
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 86 (7) , 780-782
- https://doi.org/10.1016/s0002-9149(00)01081-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring Abciximab (ReoPro)Catheterization and Cardiovascular Interventions, 1999
- A novel vascular sealing device for closure of percutaneous arterial access sitesThe American Journal of Cardiology, 1999
- Vasoseal hemostasis following coronary interventions with AbciximabCatheterization and Cardiovascular Diagnosis, 1998
- Efficacy and Safety of a Hemostatic Puncture Closure Device With Early Ambulation After Coronary AngiographyThe American Journal of Cardiology, 1998
- Femoral artery hemostasis using an implantable device (Angio-Seal™) after coronary angioplastyCatheterization and Cardiovascular Diagnosis, 1996
- Initial experience using Prostar™: A new device for percutaneous suture-mediated closure of arterial puncture sitesCatheterization and Cardiovascular Diagnosis, 1996
- Exact logistic regression: Theory and examplesStatistics in Medicine, 1995
- Efficacy and safety of collagen implants for haemostasis of the vascular access site after coronary balloon angioplasty and coronary stent implantationEuropean Heart Journal, 1995
- A new hemostatic puncture closure device for the immediate sealing of arterial puncture sitesThe American Journal of Cardiology, 1993
- ORDINAL REGRESSION MODELS FOR EPIDEMIOLOGIC DATAAmerican Journal of Epidemiology, 1989